Comorbidity of Attention Deficit Hyperactivity Disorder (ADHD) and Chung‐Jansen Syndrome: Case Report and Review of Literature
Open Access
- 10 December 2025
- journal article
- review article
- Published by Wiley in Clinical Case Reports
- Vol. 13 (12)
Abstract
Chung‐Jansen Syndrome (CJS) is a rare autosomal dominant neurodevelopmental disorder caused by heterozygous mutations in the PHIP gene (6q14.1). It is characterized by developmental delay, intellectual disability, behavioral disturbances including autism spectrum disorder and attention deficit hyperactivity disorder, obesity, and distinct facial dysmorphism such as synophrys and an upturned nose. Although clinical presentations vary, behavioral problems and delayed motor and speech milestones are common. We report a 7‐year‐old male with delayed motor and speech development, synophrys, and an upturned nose—features that are rarely documented in CJS. The patient exhibited significant resistance to multiple psychotropic treatments and presented with severe psychological and neurological symptoms. Whole Exome Sequencing revealed pathogenic mutations in both the PHIP and CLCN4 genes. The PHIP mutation was associated with core neuropsychiatric symptoms, including anxiety and depression, whereas the CLCN4 mutation contributed to severe brain atrophy observed in neuroimaging, further exacerbating cognitive and behavioral deficits. Additional copy number variations (CNVs) were detected, indicating a complex genetic background. The interplay between PHIP and CLCN4 mutations appeared to disrupt neuronal growth and synaptic function, thereby intensifying the clinical phenotype. The constellation of symptoms, including resistance to standard therapies, highlights how genetic overlap can aggravate neurodevelopmental and psychiatric manifestations in CJS. This case underscores the necessity of comprehensive genetic testing, including whole exome sequencing and CNV analysis, in patients with atypical or severe presentations of CJS. The findings emphasize that genetic interactions can amplify clinical severity and advocate for further research into the molecular mechanisms underlying such complex syndromes to improve diagnostic precision and inform targeted therapeutic strategies.Keywords
All Related Versions
This publication has 8 references indexed in Scilit:
- The detection of a strong episignature for Chung–Jansen syndrome, partially overlapping with Börjeson–Forssman–Lehmann and White–Kernohan syndromesHuman Genetics, 2024
- Novel variants in the CLCN4 gene associated with syndromic X-linked intellectual disabilityFrontiers in Neurology, 2023
- Chung–Jansen syndrome can mimic Cornelia de Lange syndrome: Another player among chromatinopathies?American Journal of Medical Genetics Part A, 2023
- PHIP-associated Chung-Jansen syndrome: Report of 23 new individualsFrontiers in Cell and Developmental Biology, 2023
- PHIP variants associated with Chung–Jansen syndrome disrupt replication fork stability and genome integrityCold Spring Harbor Molecular Case Studies, 2022
- Chung–Jansen Syndrome with obesityObesity Research & Clinical Practice, 2021
- Interpersonal difficulties in obesity: A systematic review and meta-analysis to inform a rejection sensitivity-based modelNeuroscience & Biobehavioral Reviews, 2019
- De novo and inherited mutations in the X-linked gene CLCN4 are associated with syndromic intellectual disability and behavior and seizure disorders in males and femalesMolecular Psychiatry, 2016